🇺🇸 FDA
Pipeline program

Enema transplant of fecal microbiota 25g/100mL

APHP241418

Phase 2 small_molecule active

Quick answer

Enema transplant of fecal microbiota 25g/100mL for Austistic spectrum disorder is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Austistic spectrum disorder
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials